Commentary: Evidence over dogma: Lung transplant for posthematopoietic stem cell transplant related pulmonary failure

J Thorac Cardiovasc Surg. 2022 Apr;163(4):1559-1560. doi: 10.1016/j.jtcvs.2020.11.038. Epub 2020 Nov 20.

Authors

Jesse M Rappaport¹, Usman Ahmad²

Affiliations

¹ Department of Cardiothoracic Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
² Department of Cardiothoracic Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: ahmadu@ccf.org.

PMID: 33419546
DOI: 10.1016/j.jtcvs.2020.11.038

No abstract available

Publication types

Editorial
Comment

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Lung Transplantation* / adverse effects
Respiratory Insufficiency*
Stem Cell Transplantation